Current Assets
Inventories
Bristol-Myers Squibb Inventories increased by 2.5% to $2.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $2.67B to $2.76B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 20.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Rising inventory levels may indicate anticipated sales growth or potential overproduction and obsolescence risk.
Detailed definition
This includes the value of raw materials, work-in-progress, and finished pharmaceutical products held for sale. It is a...
Peer comparison
Inventory levels are highly dependent on the drug pipeline and supply chain complexity common in the pharmaceutical sector.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $876M | $774M | $909M | $843M | $661M | $599M | $484M | $523M | $720M | $847M | $2.66B | $2.99B | $3.08B | $3.33B | $2.56B | $2.67B | $2.74B | $2.76B | $2.69B | $2.76B |
| QoQ Change | — | -11.6% | +17.4% | -7.3% | -21.6% | -9.4% | -19.2% | +8.1% | +37.7% | +17.6% | +214.3% | +12.1% | +3.1% | +8.3% | -23.3% | +4.3% | +2.7% | +0.8% | -2.5% | +2.5% |
| YoY Change | — | — | — | — | -24.5% | -22.6% | -46.8% | -38.0% | +8.9% | +41.4% | +450.0% | +470.7% | +327.4% | +293.4% | -3.9% | -10.7% | -11.0% | -17.2% | +5.2% | +3.4% |
Range$484M – $3.33B
CAGR+27.3%
Avg YoY Growth+89.1%
Median YoY Growth-0.3%
Inventories at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's inventories?
- Bristol-Myers Squibb (BMY) reported inventories of $2.76B in Q1 2026.
- How has Bristol-Myers Squibb's inventories changed year-over-year?
- Bristol-Myers Squibb's inventories increased by 3.4% year-over-year, from $2.67B to $2.76B.
- What is the long-term trend for Bristol-Myers Squibb's inventories?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's inventories has grown at a 20.0% compound annual growth rate (CAGR), from $1.08B to $2.69B.
- What does inventories mean?
- The total value of all goods and materials the company currently has in stock.